Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pfizer AS
AS
Active
Org 915213596
Drammensveien 288, 0283
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1959 · 66 years old
60 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Pfizer AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2.5B
1.9B
1.3B
0.6B
0B
2021: 1.9B
1.9B
2021
2022: 2.0B (+5% vs 2021)
2.0B
+5%
2022
2023: 1.2B (-42% vs 2022)
1.2B
-42%
2023
2024: 1.0B (-16% vs 2023)
1.0B
-16%
2024
2025: 1.1B (+10% vs 2024)
1.1B
+10%
2025
EBITDA
NOK millions
122M
92M
61M
31M
0M
2021: 98M
98M
2021
2022: 64M (-35% vs 2021)
64M
-35%
2022
2023: 13M (-80% vs 2022)
13M
-80%
2023
2024: 24M (+85% vs 2023)
24M
+85%
2024
2025: 25M (+4% vs 2024)
25M
+4%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 075 251
974 528
1 165 506
2 013 570
1 913 687
Staff expenses
−161 083
−187 933
−195 841
−179 566
−180 866
EBITDA
25 459
24 320
12 750
63 739
98 171
Depreciation & amort.
−5 341
−5 663
−3 682
−3 678
−6 673
EBIT
20 118
18 657
9 068
60 061
91 498
Net financials
13 456
24 118
19 702
29 124
−9 125
Profit before tax
33 574
42 775
28 770
89 185
82 373
Tax
7 422
9 890
7 003
20 542
18 604
Net profit
26 152
32 885
21 767
68 643
63 769
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
805 064
953 435
1 142 999
1 332 958
855 365
Equity
318 142
296 364
465 781
444 514
375 816
Long-term debt
0
0
0
0
0
Short-term debt
437 015
611 939
575 634
845 287
433 303
Total debt
437 015
611 939
575 634
845 287
433 303
Financial ratios
5-year trend
EBITDA margin
2,4 %
This company
15,8 %
Market median
This company
Market median
85% below market
2021
2025
Equity ratio
39,5 %
This company
38,2 %
Market median
This company
Market median
3% above market
2021
2025
Return on equity
8,2 %
This company
18,4 %
Market median
This company
Market median
55% below market
2021
2025
Net profit margin
2,4 %
This company
8,1 %
Market median
This company
Market median
70% below market
2021
2025
Asset turnover
1,34×
This company
1,12×
Market median
This company
Market median
20% above market
2021
2025
Debt / equity
1,53×
This company
0,62×
Market median
This company
Market median
147% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-12-01 – 2025-11-30
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-12-01 – 2024-11-30
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-12-01 – 2023-11-30
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-12-01 – 2022-11-30
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-12-01 – 2021-11-30
View
PDF
More on Pfizer AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
